The IRA, T cell therapies & distilling innovations
Assessing results from BioCentury’s Inflation Reduction Act survey and CMS’s latest guidance on the act
By Jeff Cranmer, Executive Editor
March 21, 2023 1:09 AM UTC
On the latest BioCentury This Week podcast, BioCentury’s editors assess how companies are upending pipeline and business strategies due to the Inflation Reduction Act, along with other takeaways from a survey on the IRA’s implications, conducted by BioCentury with the support of BIO.
They also discuss CMS’s memo outlining how it intends to implement the IRA’s price-setting provisions, the T cell therapy landscape and insights from BioCentury’s Distillery.
This week’s podcast is sponsored by Jeito Capital. For information on how to sponsor BioCentury This Week and/or The BioCentury Show, please contact Sarah Shoaff at sarah.shoaff@biocentury.com.
